697
Views
0
CrossRef citations to date
0
Altmetric
Cardiology & Cardiovascular Disorders

Diagnostic value of uric acid to high-density lipoprotein cholesterol ratio in abdominal aortic aneurysms

, , , , , , & show all
Article: 2357224 | Received 22 Feb 2024, Accepted 05 Apr 2024, Published online: 23 May 2024

References

  • Katsuki S, et al. Nanoparticle-Mediated delivery of pitavastatin to monocytes/macrophages inhibits angiotensin II-Induced abdominal aortic aneurysm formation in apoe(-/-) mice. J Atheroscler Thromb. 2022;29(1):1–8.
  • Li Y, Wang DD, Ley SH, et al. Potential impact of time trend of Life-Style factors on cardiovascular disease burden in China. J Am Coll Cardiol. 2016;68(8):818–833. doi: 10.1016/j.jacc.2016.06.011.
  • Kaluza J, Stackelberg O, Harris HR, et al. Anti-inflammatory diet and risk of abdominal aortic aneurysm in two swedish cohorts. Heart. 2019;105(24):1876–1883. doi: 10.1136/heartjnl-2019-315031.
  • Meital LT, et al. Abdominal aortic aneurysm and omega-3 polyunsaturated fatty acids: mechanisms, animal models, and potential treatment. Prostaglandins Leukot Essent Fatty Acids. 2017;118:1–9.
  • Deeg MA, et al. Prognostic and predictive biomarkers of abdominal aortic aneurysm growth rate. Curr Med Res Opin. 2016;32(3):509–517.
  • Burillo E, Lindholt JS, Molina-Sánchez P, et al. ApoA-I/HDL-C levels are inversely associated with abdominal aortic aneurysm progression. Thromb Haemost. 2015;113(6):1335–1346. doi: 10.1160/TH14-10-0874.
  • Liu XT, et al. High-density lipoprotein cholesterol and in-hospital mortality in patients with acute aortic dissection. J Huazhong Univ Sci Technolog Med Sci. 2016;36(3):364–367.
  • Du X, et al. Diagnostic value of monocyte to high-density lipoprotein ratio in acute aortic dissection in a chinese han population. Expert Rev Mol Diagn. 2020;20(12):1243–1252.
  • Otaki Y, Watanabe T, Konta T, et al. Impact of hyperuricemia on mortality related to aortic diseases: a 3.8-year nationwide community-based cohort study. Sci Rep. 2020;10(1):14281. doi: 10.1038/s41598-020-71301-6.
  • Dehlin M, Jacobsson L, Roddy E. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol. 2020;16(7):380–390. doi: 10.1038/s41584-020-0441-1.
  • Li X, et al. Uric acid in aortic dissection: a meta-analysis. Clin Chim Acta. 2018;484:253–257.
  • Wang J-C, Tsai S-H, Chien W-C, et al. Association between gout and abdominal aortic aneurysm. J Cardiol. 2023;82(4):274–278.
  • Wang J-C, Tsai S-H, Tsai H-Y, et al. Hyperuricemia exacerbates abdominal aortic aneurysm formation through the URAT1/ERK/MMP-9 signaling pathway. BMC Cardiovasc Disord. 2023;23(1):55. doi: 10.1186/s12872-022-03012-x.
  • Aydın C, Emlek N. The relationship between uric acid to high-density lipoprotein cholesterol ratio and collateral index in patients with chronic total occlusion. Kardiologiia. 2021;61(9):61–65. doi: 10.18087/cardio.2021.9.n1750.
  • Kurtkulagi O, Tel BMA, Kahveci G, et al. Hashimoto’s thyroiditis is associated with elevated serum uric acid to high density lipoprotein-cholesterol ratio. Rom J Intern Med. 2021;59(4):403–408. doi: 10.2478/rjim-2021-0023.
  • Kosekli MA, Kurtkulagii O, Kahveci G, et al. The association between serum uric acid to high density lipoprotein-cholesterol ratio and non-alcoholic fatty liver disease: the abund study. Rev Assoc Med Bras (1992). 2021;67(4):549–554. (1992),
  • Aktas G, Khalid A, Kurtkulagi O, et al. Poorly controlled hypertension is associated with elevated serum uric acid to HDL-cholesterol ratio: a cross-sectional cohort study. Postgrad Med. 2022;134(3):297–302. doi: 10.1080/00325481.2022.2039007.
  • Kocak MZ, et al. Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Rev Assoc Med Bras. (1992), 2019;65(1):9–15.
  • Yazdi F, et al. Investigating the relationship between ­serum uric acid to high-density lipoprotein ratio and metabolic syndrome. Endocrinol Diabetes Metab. 2022;5(1):e00311.
  • Liu R, et al. Uric acid to high-density lipoprotein cholesterol ratio predicts cardiovascular mortality in patients on peritoneal dialysis. Nutr Metab Cardiovasc Dis. 2021;31(2):561–569.
  • Chen S, Yang D, Lei C, et al. Identification of crucial genes in abdominal aortic aneurysm by WGCNA. PeerJ. 2019;7:e7873. doi: 10.7717/peerj.7873.
  • Wang Y, et al. An integrated fluid-chemical model toward modeling the thrombus formation in an idealized model of aortic dissection. Comput Biol Med. 2021;136:104709.
  • Xu J, Chen Y-Q, Zhao S-P, et al. Determination of optimal cut-off points after a high-fat meal corresponding to fasting elevations of triglyceride and remnant cholesterol in chinese subjects. Lipids Health Dis. 2019;18(1):206. doi: 10.1186/s12944-019-1146-9.
  • Aktas G, Yilmaz S, Kantarci DB, et al. Is serum uric acid-to-HDL cholesterol ratio elevation associated with diabetic kidney injury? Postgrad Med. 2023;135(5):519–523. doi: 10.1080/00325481.2023.2214058.
  • Liang WY, et al. Uric acid promotes chemokine and adhesion molecule production in vascular endothelium via nuclear factor-kappa B signaling. Nutr Metab Cardiovasc Dis. 2015;25(2):187–194.
  • Kang D-H, Park S-K, Lee I-K, et al. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005;16(12):3553–3562. doi: 10.1681/ASN.2005050572.
  • Klauser AS, Halpern EJ, Strobl S, et al. Dual-Energy computed tomography detection of cardiovascular monosodium urate deposits in patients with gout. JAMA Cardiol. 2019;4(10):1019–1028. doi: 10.1001/jamacardio.2019.3201.
  • Barazani SH, et al. Quantification of uric acid in vasculature of patients with gout using dual-energy computed tomography. World J Radiol. 2020;12(8):184–194.
  • Patetsios P, Rodino W, Wisselink W, et al. Identification of uric acid in aortic aneurysms and atherosclerotic artery. Ann N Y Acad Sci. 1996;800:243–245.
  • Atıl A, Deniz A. Could be serum uric acid a risk factor for thrombosis and/or uveitis in behcet’s disease? Vascular. 2018;26(4):378–386. doi: 10.1177/1708538117742831.
  • Wang X, et al. The preoperative uric acid-to-Albumin ratio as a new indicator to predict Long-Term prognosis after surgery for patients with acute type a aortic dissection. Heart Surg Forum. 2023;26(1):E001–E008.
  • Nasonova VA, Zakharova MM, Barskova VG[, et al. Detection of sodium monourate crystals in biopsies of gastric mucosa in patients with gout]. Ter Arkh. 2004;76(6):47–51.
  • Kang D-H, Nakagawa T, Feng L, et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol. 2002;13(12):2888–2897. doi: 10.1097/01.asn.0000034910.58454.fd.
  • Yan B, et al. The effects of hyperuricemia on the differentiation and proliferation of osteoblasts and vascular smooth muscle cells are implicated in the elevated risk of osteopenia and vascular calcification in gout: an in vivo and in vitro analysis. J Cell Biochem. 2019;120(12):19660–19672.
  • Kanellis J, Watanabe S, Li JH, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in ­vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension. 2003;41(6):1287–1293. doi: 10.1161/01.HYP.0000072820.07472.3B.
  • Li Y, Liu X, Luo Y. Monocyte to high-density lipoprotein cholesterol ratio and serum uric acid in chinese adults: a cross-sectional study. BMC Endocr Disord. 2022;22(1):48. doi: 10.1186/s12902-022-00966-z.
  • Liu H, Liu J, Zhao H, et al. Relationship between serum uric acid and vascular function and structure markers and gender difference in a Real-World population of China-from beijing vascular disease patients evaluation study (BEST) study. J Atheroscler Thromb. 2018;25(3):254–261. doi: 10.5551/jat.39685.
  • Nagao M, Nakajima H, Toh R, et al. Cardioprotective ­effects of high-density lipoprotein beyond its anti-Atherogenic action. J Atheroscler Thromb. 2018;25(10):985–993. doi: 10.5551/jat.RV17025.
  • Manandhar B, Cochran BJ, Rye KA. Role of high-density lipoproteins in cholesterol homeostasis and glycemic control. J Am Heart Assoc. 2020;9(1):e013531.
  • Meas T, et al. Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile. Eur J Intern Med. 2009;20(2):197–200.
  • Vekic J, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V, et al. High serum uric acid and low-grade inflammation are associated with smaller LDL and HDL particles. Atherosclerosis. 2009;203(1):236–242. doi: 10.1016/j.atherosclerosis.2008.05.047.
  • Razavi AC, Jain V, Grandhi GR, et al. Does elevated high-density lipoprotein cholesterol protect against cardiovascular disease? J Clin Endocrinol Metab. 2024;109(2):321–332. doi: 10.1210/clinem/dgad406.
  • Derosa G, Maffioli P, Sahebkar A. Plasma uric acid concentrations are reduced by fenofibrate: a systematic review and meta-analysis of randomized placebo-controlled trials. Pharmacol Res. 2015;102:63–70.
  • Zhang J, Ji X, Dong Z, et al. Impact of fenofibrate therapy on serum uric acid concentrations: a review and meta-analysis. Endocr J. 2021;68(7):829–837. doi: 10.1507/endocrj.EJ20-0808.
  • Akbari A, et al. The effect of statin therapy on serum uric acid levels: A Systematic review and meta-analysis. Curr Med Chem. 2024;31:1726–1739. doi: 10.2174/0929867330666230207124516.